J. Tabareau

Airway structural cells regulate TLR5-mediated mucosal adjuvant activity

J. Sirard, B. Ryffel, A. Benecke, 2013, Mucosal Immunology.

Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22

J. Sirard, J. Renauld, P. Gosset, 2016, Infection and Immunity.

Transgenic Mouse Model Harboring the Transcriptional Fusion Ccl20-Luciferase as a Novel Reporter of Pro-Inflammatory Response

J. Sirard, M. Rumbo, L. Van Maele, 2013, PloS one.

Sublingual flagellin protects against acute pneumococcal pneumonia in a TLR5-dependent and NLRC4-independent fashion.

J. Sirard, J. Chabalgoity, D. Fougeron, 2016, Future microbiology.

A Toll-Like Receptor 5 Agonist Improves the Efficacy of Antibiotics in Treatment of Primary and Influenza Virus-Associated Pneumococcal Mouse Infections

J. Sirard, C. Paget, F. Trottein, 2015, Antimicrobial Agents and Chemotherapy.

Recombinant flagellins with deletions in domains D1, D2, and D3: Characterization as novel immunoadjuvants.

J. Sirard, G. Parisi, M. Rumbo, 2019, Vaccine.

The Toll-Like Receptor 5 agonist flagellin prevents Non-typeable Haemophilus influenzae-induced infection in cigarette smoke-exposed mice

J. Sirard, P. Gosset, M. Pichavant, 2021, PloS one.